Ventaira Pharmaceuticals' Unattributed VC - II Round

Ventaira Pharmaceuticals raised a round of funding on March 10, 2005.

a specialty pharmaceutical company focused on developing products for inhalation by utilizing its electrohydrodynamic aerosolization technology and formulation technologies to improve the profile of n…

Articles about Ventaira Pharmaceuticals' Unattributed VC - II Round: